Marketwise (NASDAQ:MKTW) Bolsa

Marketwise

Marketwise Inc is a multi-brand subscription services platform providing premium financial research, software, education, and tools for investors. Its products are built for high-value financial research, education, actionable investment ideas, and investment software. It is a digital, direct-to-consumer company offering its research across a variety of platforms including mobile, desktops, and tablets.

Marketwise Inc

Tilray Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) traded relatively flat in premarket on Thursday, after its medical division unveiled results from a newly published pharmacokinetic study comparing<a href="https://www.benzinga.com/pressreleases/25/06/g46111752/tilray-medical-publishes-pioneering-research-on-the-pharmacokinetics-of-thc-and-cbd-formulations" target="_blank" rel="noreferrer noopener"> two cannabinoid delivery methods.</a>
The study contributes to the growing body of research on the behavior of cannabinoid formulations in the human body, aiming to inform more therapeutic decisions for patients and healthcare providers.
The study compared how the body absorbs two THC: CBD formulations—an oral Tilray extract and a nabiximols oromucosal spray.
Also Read: <a target="_blank" href="https://www.benzinga.com/cannabis/25/06/46072540/tilray-makes-history-first-to-import-and-sell-branded-medical-cannabis-in-italy" rel="noreferrer noopener">Tilray Makes History, First To Import And Sell Branded Medical Cannabis In Italy</a>
Researchers aimed to evaluate differences in absorption efficiency and pharmacokinetic responses.
The crossover pilot study, conducted in 12 fasting adult volunteers, measured blood levels of cannabinoids and their metabolites over a 24-hour period.
The study was conducted to assess comparative absorption levels, timelines, and potential differences based on gender.
Findings revealed that the oral Tilray extract yielded significantly higher peak concentrations (Cmax) for both THC and CBD when compared to nabiximols.
While the timing of peak absorption (Tmax) and overall exposure (AUC) was similar between the two formulations, the Tilray method achieved more potent levels in a shorter window.
Gender-based differences also emerged, with males showing a notably higher Cmax when administered nabiximols.
Blood samples taken at 16 intervals over a full day showed that neither THC nor CBD was detectable after 24 hours, while 11-hydroxy-THC dropped sharply from its peak levels.
Importantly, participants did not report any severe adverse reactions during the study period.
José Tempero, Tilray&#8217;s medical director, noted that the findings advance the understanding of how cannabinoids interact with the body, aiding in the development of more precise formulations.
Denise Faltishchek, the company&#8217;s chief strategy officer and head of international, added that the work reinforces Tilray's commitment to scientific leadership and to improving outcomes for medical cannabis patients worldwide.
Tilray Medical has been a major supplier of pharmaceutical-grade cannabis products, shipping to over 20 countries.
The company has participated in clinical trials globally, targeting conditions from epilepsy and cancer-related nausea to PTSD and alcohol dependency.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, TLRY stock has lost over 76% in the past year.
In a separate release, Montauk Brewing Co., a Tilray Brands company, announced a limited-edition collaboration with lifestyle brand Faherty, blending coastal-inspired craft beer <a href="https://www.benzinga.com/pressreleases/25/06/g46112869/montauk-brewing-celebrates-13-years-of-brewing-with-faherty-collaboration-and-beach-clean-up-with-" target="_blank" rel="noreferrer noopener">with breezy, beachside apparel.</a>
In addition to launching beer and apparel, the brands are partnering with the Eastern Long Island Chapter of the Surfrider Foundation for a beach cleanup event, followed by a Brew Barn celebration marking their 13-year journey on Saturday, June 28.
Price Action: TLRY shares are trading lower by 0.89% to $0.3945 premarket at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/cannabis/25/06/45997534/canadian-medical-marijuana-firm-aurora-cannabis-expects-weak-demand-in-international-market" target="_blank" rel="noreferrer noopener">Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market</a></li>
</ul>
Photo: Shutterstock

Cannabis

Equities

News

Health Care

Movers

TLRY

What's Going On With Tilray Brands Stock Today?

Global

International Atomic Energy Agency Says As Of Now, The IAEA Has Not Received An Official Communication From Iran On Any Decision To Suspend Cooperation

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 200 points on Thursday.
Following the market opening Thursday, the Dow traded up 0.49% to 43,192.54 while the NASDAQ gained 0.36% to 20,045.46. The S&amp;P 500 also rose, gaining, 0.38% to 6,115.14.
Check This Out: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/46113083/amd-taiwan-semiconductor-manufacturing-cnbc-final-trades">AMD, Taiwan Semiconductor And A Financial Stock On CNBC&#8217;s &#8216;Final Trades&#8217;</a>
Leading and Lagging Sectors Materials shares jumped by 0.8% on Thursday.
In trading on Thursday, real estate stocks fell by 0.8%.
Top Headline
The U.S. economy shrank at an annualized rate of 0.5% in the first quarter, compared to a 0.2% decline as per the second estimate.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>Cyngn Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) shares shot up 319% to $20.97 after the company announced it partnered with Nvidia to showcase its autonomous industrial vehicles at Automatica 2025.</li>
<li>Shares of Ascent Solar Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) got a boost, surging 114% to $2.49 after the company entered into a collaborative agreement with NASA.</li>
<li>Vor Biopharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) shares were also up, gaining 49% to $0.8545 after the company announced it signed a global license agreement with Remegen for its autoimmune asset telitacicept.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Globavend Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GVH#NASDAQ">GVH</a>) shares dropped 74% to $0.1835 after the company announced the pricing of a $15 million offering of 21,739,130 shares at $0.69 per share.</li>
<li>Shares of Altimmune, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) were down 60% to $3.1178 after the company announced topline results from the IMPACT Phase 2b trial of Pemvidutide in the treatment of MASH.</li>
<li>Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>) was down, falling 53% to $0.3588 after the company announced a $10 million public offering of 20 million shares and dual warrants at a combined price of $0.50 per share and accompanying warrants.</li>
</ul>
Commodities In commodity news, oil traded up 0.9% to $65.51 while gold traded down 0.6% at $3,324.20.
Silver traded up 0.4% to $36.250 on Thursday, while copper rose 2.7% to $5.1080.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 rose 0.01%, while Spain's IBEX 35 Index rose 0.1%. London's FTSE 100 rose 0.3%, Germany's DAX 40 gained 0.4% and France's CAC 40 slipped 0.2% during the session.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei gaining 1.65%, Hong Kong's Hang Seng Index falling 0.61%, China's Shanghai Composite falling 0.22% and India's BSE Sensex rising 1.21%.
Economics
<ul class="wp-block-list">
<li>The U.S. economy shrank at an annualized rate of 0.5% in the first quarter, compared to a 0.2% decline as per the second estimate.</li>
<li>U.S. initial jobless claims declined by 10,000 from the previous week to 236,000 in the week ended June 21.</li>
<li>U.S. durable goods orders climbed by 16.4% month-over-month to $343.6 billion in May compared to a revised 6.6% decline in April.</li>
<li>The U.S. trade deficit in goods increased to $96.6 billion in May from $87.0 billion in the previous month, and versus market estimates of an $88.5 billion gap.</li>
<li>The Chicago Fed National Activity Index rose to –0.28 in May compared to a revised reading of –0.36 in April.</li>
<li>U.S. wholesale inventories declined 0.3% month-over-month to $905.4 billion in May following a revised 0.1% gain in April.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/46108846/nike-likely-to-report-lower-q4-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earnings-call">Nike Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>
Photo via Shutterstock

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ASTI

RVPH

Dow Surges 200 Points; US GDP Contracts 0.5%

Guggenheim analyst Michael Morris reiterates Paramount Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>) with a Buy and maintains $14 price target.

Price Target

Reiteration

Analyst Ratings

PARA

Guggenheim Reiterates Buy on Paramount Glb, Maintains $14 Price Target

ISPO

Inspirato Shares Resumed Trade

Guggenheim analyst Curry Baker reiterates Sirius XM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIRI#NASDAQ">SIRI</a>) with a Buy and maintains $29 price target.

SIRI

Guggenheim Reiterates Buy on Sirius XM Holdings, Maintains $29 Price Target

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26083228/Ele.me-0626-900x600-1.png" alt="" class="wp-image-14915" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26083228/Ele.me-0626-900x600-1.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26083228/Ele.me-0626-900x600-1-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/06/26083228/Ele.me-0626-900x600-1-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The merger of its Ele.me service with its core e-commerce business marks a new stage in the e-commerce giant's three-way "on-demand retail wars" with Meituan and JD.com
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul class="wp-block-list">
<li>Alibaba has shut down its money-losing local services segment, absorbing its Ele.me takeout dining service into its main e-commerce business group</li>
<li>On-demand commerce has become the company's new mantra in its restructured e-commerce business as it shelves a previous breakup plan</li>
</ul>
When reports surfaced this week of an internal memo detailing yet another new restructuring at Alibaba Group Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), investors cheered by bidding up the e-commerce giant's shares by nearly 4% over the next few days. The move marked the latest dismantling of a breakup plan announced by the company two years ago, throwing it squarely into China's growing "instant retail" wars that let consumers buy anything online and get it shipped to their homes within hours.
The original breakup plan in 2023 aimed to let Alibaba's six main units operate more independently to make them more efficient. But its strategy shifted just a year later as longtime CEO Daniel Zhang departed, with reports in January 2024 that it was considering sales of consumer assets under Eddy Wu, who became the company's new CEO in September 2023.
Both Zhang and Wu were trying to reverse a slide that saw Alibaba's shares lose about half their value over the last five years. Wu started by dumping some of Alibaba's brick-and-mortar retail assets, a relic of a "new retail" model that combined e-commerce and traditional retail, including its sale of its Intime department store chain and Sun Art grocery chain for about $3 billion combined.
Alibaba's latest financial results for its fiscal year through March were considered a disappointment despite a 6% increase in revenue for the year to 996.3 billion yuan ($139 billion) and non-GAAP net income that was flat at 158 billion yuan.
Its local services group, consisting of takeout dining service Ele.me and its Fliggy travel service, was also underwhelming. The segment's revenue rose 12% to 67 billion yuan for the fiscal year, and lost 3.7 billion yuan in adjusted earnings before interest, taxes, depreciation and amortization (EBITDA). The segment reported EBITDA losses in the three previous fiscal years as well, making it look like a candidate for another asset sale as the company returned to its e-commerce roots.
But instead, Alibaba has taken just the opposite tack by drawing Ele.me and Fliggy into its core e-commerce business, which includes the Taobao and Tmall marketplaces that are considered the company's crown jewels.
The move looks set to turn up the heat in China's recently intensifying instant retail wars. The addition of Ele.me to Alibaba's new e-commerce group could quickly turn up its fire power as the meal delivery company battles longtime rival&nbsp;Meituan&nbsp;(3690.HK) and&nbsp;<a href="https://thebambooworks.com/jd-com-seeks-place-at-chinas-massive-takeout-dining-table/">newcomer</a>&nbsp;JD.com&nbsp;(JD.US; 9168.HK) in the fiercely competitive market for on-demand or instant delivery services.
The battle is no longer just about takeout dining, which saw a huge upsurge during the pandemic and has become a part of everyday life in China. Now everyone&nbsp;<a href="https://thebambooworks.com/how-did-instant-retail-trigger-chinas-second-takeout-war/">wants everything on demand</a>&nbsp;all the time, the faster the better. And companies are trying to deliver that. According to a report from the Chinese Academy of International Trade and Economic Cooperation, the country's instant retail delivery industry has grown by an average annual rate of more than 50% since 2018, to reach 650 billion yuan in 2023.&nbsp;
<h4 class="wp-block-heading">Challenging Meituan and JD.com</h4>
Alibaba's new on-demand retail services are challenging Meituan, the traditional market leader, as well as JD.com, which was providing such services through its separately listed Dada Nexus arm that it recently privatized. Bargain e-commerce upstart&nbsp;PDD&nbsp;(PDD.US), operator of the Pinduoduo service, may also be trying to get in on the act.
Ele.me's future role as an important part of Alibaba's core e-commerce business has been obvious since at least April, when Taobao rebranded its one-hour delivery service, formerly known as Xiaoshida, as Taobao Instant Commerce. As part of that shift, it recruited Ele.me as its logistics provider, taking advantage of the service's 4 million riders. All of the company's instant retail operations were consolidated under Taobao, with Ele.me offering up its huge fleet of riders for both delivery of food and other products.
As part of the ramp-up, Taobao and Ele.me said they would offer over 10 billion yuan in subsidies to attract merchants and buyers to its new instant retail network. By early June, they had achieved over 40 million daily deliveries.
Alibaba made its move more than a year after JD.com, which launched its Miaosong, or "one second delivery," instant demand retail platform in May 2024, followed by a new food delivery service in February. In a research report in early June, HSBC noted that JD.com had achieved 25 million daily deliveries since it launched the food delivery service, advertising zero commission fees for restaurants that signed up before May 1.
In April, JD.com said it would hire 50,000 more full-time couriers for Miaosong, delivering items from its network of 100,000 JD.com-branded offline stores, and adding to its existing 1.2 million to 1.3 million active riders. The same month JD.com also privatized Dada Nexus, and has pledged 10 billion yuan in subsidies for its instant retail initiatives over the next year.
Also in April, Pinduoduo announced it would invest 100 billion yuan to transform and upgrade its platform for merchants, which many interpreted as showing it would enter the instant retail race.
Meituan, the takeout dining leader with 65% of the market, double Ele.me's 33%, rebranded its 7-year-old on-demand retail business in April as well. It positioned its "Meituan Flash Purchase" as a "new generation shopping platform that accompanies consumers 24 hours a day", selling everything from home appliances to pet supplies.
Meituan said on its latest earnings call last month that its delivery network was processing 20 million orders per day. According to CFO Chen Shaohui, non-catering orders were up 60% in the quarter.
Given the intense competition, heavy spending on subsidies and continued regulatory scrutiny, who will come out on top in the new instant retail era is anybody's guess. "We see quick commerce as a huge opportunity," said Alibaba's e-commerce chief Jiang Fan on the company's latest earnings call. "It addresses a widespread, everyday need for consumers across Chinese society. Today it could be a market of 500 to 600 million consumers. Going forward, that could easily become 1 billion consumers."
Alibaba seems to have a leg up over JD.com in the instant retail race, at least in investors' eyes, with a trailing price to earnings (P/E) ratio of 18 that's well ahead of JD.com's 11. But Meituan, known for its aggressive tactics and good execution, is the clear favorite with a P/E ratio of 61.
The analyst community likes all three companies, with 35 of 42 surveyed by Yahoo Finance giving Meituan a "buy" or "strong buy" rating. JD.com looks similar, with 34 out of 37 analysts rating it a "buy" or "strong buy," while 38 out of 40 give Alibaba those two ratings. That seems to show analysts aren't ready to call a winner in the building instant retail race just yet, and much will depend on how the landscape develops in the next few years.

Asia

Opinion

Tech

BABA

Alibaba Absorbs Ele.me Escalating Retail War With Meituan And JD.com

Insider Trades

Nordic American Tankers CEO Herbjorn Hansson Buys 100K Shares At $2.74/Share, Increases Stake To 4.95M Shares

Brenmiller Energy Ltd. ("Brenmiller" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNRG#NASDAQ">BNRG</a>), a global leader provider of thermal energy storage ("TES") solutions for industrial and utility customers, and a major Japanese Corporation, which is a prominent Japan-based engineering and project development company, announced today the signing of a non-binding Memorandum of Understanding ("MOU") to collaborate on the deployment of sustainable heating solutions in Japan.

BNRG

Brenmiller Energy Signs Non-Binding MOU To Collaborate On Deployment Of Sustainable Heating Solutions In Japan

ISPOW

Trading Halt: Halt status updated at 9:50:00 AM ET: Quotation Resumption: News and Resumption Times

Citigroup analyst Christopher Danely maintains Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) with a Buy and raises the price target from $130 to $150.

Citigroup Maintains Buy on Micron Technology, Raises Price Target to $150

Citigroup analyst Scott Gruber maintains Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) with a Neutral and lowers the price target from $19 to $17.

Citigroup Maintains Neutral on Helmerich & Payne, Lowers Price Target to $17

Trading Halt: Halt status updated at 9:45:00 AM ET: Quotation Resumption: News and Resumption Times

Wedbush analyst Matt Bryson maintains Micron Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) with a Outperform and raises the price target from $150 to $165.

Wedbush Maintains Outperform on Micron Technology, Raises Price Target to $165

Cyngn Shares Halted On Circuit Breaker To The Upside, Stock Now Up 318.6%

Wedbush analyst David Nierengarten reiterates Vor Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) with a Neutral and maintains $0.4 price target.

Wedbush Reiterates Neutral on Vor Biopharma, Maintains $0.4 Price Target

Cyngn Shares Resume Trade

Citigroup analyst Keith Horowitz maintains JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) with a Neutral and raises the price target from $250 to $275.

Citigroup Maintains Neutral on JPMorgan Chase, Raises Price Target to $275

<a href="https://www.richmondfed.org/press_room/media_advisories/2025/20250623_barkin_ny#:~:text=Richmond%20Fed%20President%20Tom%20Barkin,%2C%202025%2C%20in%20New%20York.&amp;text=Speech%20is%20scheduled%20for%208,event%20also%20includes%20audience%20Q%26A" title="https://www.richmondfed.org/press_room/media_advisories/2025/20250623_barkin_ny#:~:text=Richmond%20Fed%20President%20Tom%20Barkin,%2C%202025%2C%20in%20New%20York.&amp;text=Speech%20is%20scheduled%20for%208,event%20also%20includes%20audience%20Q%26A">https://www.richmondfed.org/press_room/media_advisories/2025/20250623_barkin_ny#:~:text=Richmond%20Fed%20President%20Tom%20Barkin,%2C%202025%2C%20in%20New%20York.&amp;text=Speech%20is%20scheduled%20for%208,event%20also%20includes%20audience%20Q%26A</a>

Macro Economic Events

Economics

Federal Reserve

Fed's Barkin Questions How Successful Firms Will Be In Trying To Pass Through Tariff Increases; Worries About Taking Too Much Signal From University Of Michigan Sentiment Data; Says Hiking Rates Does Not Seem Like The Topic Of Day Amid Cooling Inflation Trend

Press Releases

MarketWise Inc. Reports Preliminary Selected Unaudited Fourth Quarter 2024 Billings of $55 Million, over a 10% Increase from Prior Quarter; Announces Special Dividend of $0.03 Per Share

MarketWise to present at the UBS Financial Services Forum on February 11, 2025

Earnings

MarketWise Reports Net Income of $93.1 Million and Net Revenue of $408.7 Million for Full Year 2024, and Announces Stock Repurchase Program of up to $50 Million

Dividends

MarketWise Declares Dividend on Common Stock

MarketWise Announces 1-for-20 Reverse Stock Split

MarketWise Inc. Reports Preliminary Selected Unaudited First Quarter Billings of $70 Million, Over a 26% Increase from Prior Quarter; Commences Share Buyback Program; LTM Cash Dividend Yield Totals 16%

MarketWise Declares Quarterly Dividend of $0.20 Per Share on Common Stock; Announces Special Dividend of $0.10 Per Share

MarketWise to Present at the UBS SMID-Cap Multisector Virtual Conference on June 24, 2025

MarketWise Reports Net Revenue of $83.5 Million for First Quarter 2025 and Net Income of $16.8 Million; First Quarter Billings Increase 27% from Prior Quarter; Cash From Operating Activities Improves by $20.2 Million; Provides FY 2025 Financial Targets; Announced Quarterly and Special Dividend Totaling $0.30 per Class A Share

Comments

Marketwise

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL